Total amount raised
$165 Millions
Latest funding date
1/1/2025
Location
Suki has successfully raised significant funding over multiple rounds, attracting a diverse group of investors. The company focuses on providing an AI-powered assistant designed to streamline documentation tasks for clinicians.
Keep reading to explore the intricacies of Suki's fundraising journey and the investors backing this innovative platform.
What Is Suki?
Suki, founded on November 15, 2016, is headquartered in Redwood City, California. The company specializes in AI-powered voice solutions aimed at streamlining healthcare documentation processes.
Founded by Anshu Sharma, Karthik Rajan, and Punit Soni, Suki has grown to employ between 101 and 250 people. Their primary product, Suki Assistant, helps clinicians complete administrative tasks more efficiently.
With a focus on deep integration with major Electronic Health Records (EHR) systems, Suki ensures that its solutions are both effective and reliable, making it a valuable tool for healthcare professionals.
How Much Funding Has Suki Raised?
- Seed Round
- Amount Raised: $5M
- Date: March 2016
- Lead Investors: Bradley Horowitz
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop the initial version of Suki's AI-powered voice solutions.
- Series A
- Amount Raised: $15M
- Date: May 2018
- Lead Investors: Venrock
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the team and enhance product development.
- Series B
- Amount Raised: $20M
- Date: March 2020
- Lead Investors: Flare Capital Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and integrate with major EHR systems.
- Series C
- Amount Raised: $55M
- Date: December 2021
- Lead Investors: March Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate market expansion and product innovation.
- Series D
- Amount Raised: $70M
- Date: October 2024
- Lead Investors: Hedosophia
- Valuation at Round: Approximately $500M
- Motivation Behind the Round: To accelerate product development, add more features, and build tools to manage multiple AI models.
- Venture Round
- Amount Raised: Not publicly disclosed
- Date: January 2025
- Lead Investors: Zoom Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further enhance AI capabilities and expand strategic partnerships.
Total Amount Raised: $165M. Current Valuation: Approximately $500M.
Key Investors
- Zoom Ventures
- Details: Zoom Ventures is a venture capital firm that invests in innovative technology companies. They are known for their strategic investments in high-growth sectors.
- Investment Focus Areas: Technology, innovation, healthcare.
- Notable Investments: Not publicly disclosed.
- Hedosophia
- Details: Hedosophia is a London-based tech investment firm. They focus on backing innovative startups and growth-stage companies.
- Investment Focus Areas: Technology, innovative startups, healthcare AI.
- Notable Investments: Not publicly disclosed.
- March Capital
- Details: March Capital is a venture capital firm that invests in technology companies across various stages. They are known for their focus on AI and healthcare technology.
- Investment Focus Areas: Technology, AI, healthcare.
- Notable Investments: Not publicly disclosed.
- Flare Capital Partners
- Details: Flare Capital Partners is a venture capital firm specializing in healthcare technology. They support early-stage companies aiming to transform healthcare.
- Investment Focus Areas: Healthcare technology, digital health, medical devices.
- Notable Investments: Not publicly disclosed.
- Venrock
- Details: Venrock is a venture capital firm with a long history of investing in technology and healthcare. They have been involved in some of the most successful early-stage investments.
- Investment Focus Areas: Technology, healthcare, energy.
- Notable Investments: Apple, Intel, Gilead Sciences.
What's Next for Suki?
Suki stands at the cusp of significant growth opportunities, driven by the increasing demand for AI solutions in healthcare. With a recent $70 million Series D funding round, the company is well-positioned to expand its partnerships with health systems and enhance its AI voice assistants. The integration with major Electronic Health Record (EHR) systems and the rise of generative AI technologies like OpenAI's ChatGPT further amplify Suki's potential to revolutionize healthcare documentation.
Future fundraising opportunities appear promising as Suki continues to attract investment to support its rapid growth and product development. However, the company faces challenges such as competition from established players like Microsoft-owned Nuance and the need to continuously innovate. Ensuring seamless integration with various EHR systems and maintaining high adoption rates among clinicians will be crucial for Suki's sustained success.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Suki and gather other critical business insights.
Sign up for free on Clay and start making data-driven decisions today.
